advertisement
Gene Therapy 17
Showing records 1 to 17 | Display only abstracts in Gene Therapy from IGR 22-3109397 Tolerability and tropism of recombinant adeno-associated virus vectors in the African green monkey (Chlorocebus sabaeus) anterior chamber
Chern KJ; Issac KZ; Gumbs ZD; O'Connor ME; Lawrence MS; Lipinski DM
Gene Therapy 2023; 30: 714-722 (IGR: 24-1/2)
95982 XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma
Visuvanathan S; Baker AN; Lagali PS; Coupland SG; Miller G; Hauswirth WW; Tsilfidis C
Gene Therapy 2022; 29: 147-156 (IGR: 22-3)
92783 Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes
Lee EJ; Han JC; Park DY; Cho J; Kee C
Gene Therapy 2021; 28: 277-286 (IGR: 22-1)
82607 Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics
Rodriguez-Estevez L; Asokan P; Borrás T
Gene Therapy 2019; 0: (IGR: 20-4)
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Borrás T
Gene Therapy 2016; 23: 438-449 (IGR: 17-4)
67591 Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Boyd RF
Gene Therapy 2016; 23: 548-556 (IGR: 17-4)
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Buie LK
Gene Therapy 2016; 23: 438-449 (IGR: 17-4)
67591 Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Boye SL; Conlon TJ
Gene Therapy 2016; 23: 548-556 (IGR: 17-4)
66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Spiga MG
Gene Therapy 2016; 23: 438-449 (IGR: 17-4)
67591 Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Erger KE; Sledge DG; Langohr IM; Hauswirth WW; Komáromy AM; Boye SE; Petersen-Jones SM; Bartoe JT
Gene Therapy 2016; 23: 548-556 (IGR: 17-4)
47749 Gene therapy for retinal ganglion cell neuroprotection in glaucoma
Wilson AM; Di Polo A
Gene Therapy 2011; (IGR: 13-4)
22898 Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma
Munemasa Y; Ahn JH; Kwong JMK; Caprioli J; Piri N
Gene Therapy 2009; 16: 17-25 (IGR: 11-1)
14595 AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells
Leaver SG; Cui Q; Plant GW; Arulpragasam A; Hisheh S; Verhaagen J; Harvey AR
Gene Therapy 2006; 13: 1328-1341 (IGR: 8-4)
10666 Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension
Heatley G; Kiland J; Faha B; Seeman J; Schlamp CL; Dawson DG; Gleiser J; Maneval D; Kaufman PL; Nickels RW
Gene Therapy 2004; 11: 949-955 (IGR: 6-2)
8550 Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome
Cordeiro MF; Mead AL; Ali RR; Alexander RA; Murray S; Chen C; York-Defalco C; Dean NM; Schultz GS; Khaw PT
Gene Therapy 2003; 10: 59-71 (IGR: 5-1)
3589 Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy
Lai YKY; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE
Gene Therapy 2002; 9: 804-813 (IGR: 4-2)
5452 Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma
Borras T; Rowlette LL; Erzurum SC; Epstein DL
Gene Therapy 1999; 6: 515-524 (IGR: 1-2)
